Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 235 | Pages: 171 | December 2016 | Region: Global


The Global Plasma Protein Therapeutics Market is estimated to be at USD 19.2 Billion in 2015 and is poised to reach USD 27.56 Billion by 2020 with a CAGR of 7.5%. The use of plasma protein in the medical applications has increased significantly in the recent years. With the advancements in technology, the process for fractionating the protein from plasma has become more cost saving and efficient and is supposed to boost the plasma protein therapeutics market. According to WHO reports more than half of the global blood donors belong to high income countries which constitutes 18% of the population. With rising awareness among people regarding blood donations and government initiatives, plasma derived medicine market is expected to grow at a significant rate in the coming years.

Plasma is a protein rich fluid and plays a crucial role in clotting and providing immunity to diseases. By isolating the proteins from plasma, they can used for medical therapies including autoimmune, immune deficiencies, neurological and bleeding disorders. Plasma protein therapies are used to treat well-defined medical condition by replacing the deficient or missing proteins in plasma. Plasma protein therapeutics involves biological medicines either infused or injected to treat life-threatening, chronic and genetic diseases.

Increasing introduction of new plasma-derived therapies is the primary driving factor for the market. The market is also driven by a host of other factors, including rising prevalence of life threatening diseases involving immune or neurological systems and other infectious diseases like Rabies, Tetanus, Hepatitis A&B and varicella. On the contrary there are a few restraints for market which includes stringent government policies, issues pertaining to reimbursement, complexity in manufacturing.

The Global Plasma Protein Therapeutics Market is segmented based on product type as Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others. On the basis of application the market is categorised as Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others. Based on geographical region, the market is analysed in the regions of North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

The major players in the plasma protein therapeutic market are Baxter, CSL Behring, Biotest, China Biologics, Grifols, Kedrion, Octapharma, Shire Plc., and Chengdu Inst.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 Others                                                      

6. Geographical Analysis                                                                                              

                6.1 North America                                                                          

                                6.1.1 Introduction                                                           

                                6.1.2 United States                                                         

                                6.1.3 Canada                                                     

                6.2 Europe                                                                         

                                6.2.1 Introduction                                                           

                                6.2.2 U.K                                                             

                                6.2.3 Spain                                                         

                                6.2.4 Germany                                                 

                                6.2.5 Italy                                                            

                                6.2.6 France                                                       

                6.3 Asia-Pacific                                                                 

                                6.3.1 Introduction                                                           

                                6.3.2 China                                                         

                                6.3.3 India                                                          

                                6.3.4 Japan                                                         

                                6.3.5 South Korea                                                           

                                6.3.6 Australia                                                   

                6.4 Latin America                                                                             

                                6.4.1 Introduction                                                           

                                6.4.2 Brazil                                                          

                                6.4.3 Mexico                                                     

                                6.4.4 Rest of Latin America                                                          

                6.5 Middle East & Africa                                                                               

                                6.5.1 Introduction                                                           

                                6.5.2 Middle-East                                                            

                                6.5.3 Africa                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)                                                                                                                                                          
  2. Global Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)                                                                                                                                                             
  3. Global Immunoglobulins Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                            
  4. Global Albumin Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                               
  5. Global Coagulation Factors Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                        
  6. Global Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                       
  7. Global Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                  
  8. Global Hemophilia Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                         
  9. Global Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                       
  10. Global Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                   
  11. Global Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                   
  12. Global Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                  
  13. North America Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)                                                                                                                                                         
  14. North America Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)                                                                                                                                                             
  15. North America Immunoglobulins Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                            
  16. North America Albumin Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                              
  17. North America Coagulation Factors Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                       
  18. North America Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                      
  19. North America Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                 
  20. North America Hemophilia Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                        
  21. North America Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                      
  22. North America Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                  
  23. North America Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                   
  24. North America Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                 
  25. Europe Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)                                                                                                                                                        
  26. Europe Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)                                                                                                                                                            
  27. Europe Immunoglobulins Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                           
  28. Europe Albumin Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                             
  29. Europe Coagulation Factors Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                      
  30. Europe Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                     
  31. Europe Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                
  32. Europe Hemophilia Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                       
  33. Europe Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                     
  34. Europe Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                 
  35. Europe Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                  
  36. Europe Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                
  37. Asia-Pacific Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)                                                                                                                                                
  38. Asia-Pacific Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)                                                                                                                                                    
  39. Asia-Pacific Immunoglobulins Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                   
  40. Asia-Pacific Albumin Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                     
  41. Asia-Pacific Coagulation Factors Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                              
  42. Asia-Pacific Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                             
  43. Asia-Pacific Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                        
  44. Asia-Pacific Hemophilia Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                               
  45. Asia-Pacific Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                             
  46. Asia-Pacific Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                         
  47. Asia-Pacific Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                          
  48. Asia-Pacific Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                        
  49. Latin America Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)                                                                                                                                                            
  50. Latin America Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)                                                                                                                                                               
  51. Latin America Immunoglobulins Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                              
  52. Latin America Albumin Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                
  53. Latin America Coagulation Factors Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                          
  54. Latin America Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                         
  55. Latin America Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                   
  56. Latin America Hemophilia Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                          
  57. Latin America Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                        
  58. Latin America Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                     
  59. Latin America Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                     
  60. Latin America Others Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                   
  61. Middle East & Africa Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)                                                                                                                                                              
  62. Middle East & Africa Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)                                                                                                                                                  
  63. Middle East & Africa Immunoglobulins Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                 
  64. Middle East & Africa Albumin Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                   
  65. Middle East & Africa Coagulation Factors Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                            
  66. Middle East & Africa Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)                                                                                                                                                       &nbs
Middle East and Africa Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, N...
Latin America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gener...
Asia-Pacific Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Genera...
Europe Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation s...
North America Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Gene...
Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation sequenci...
Middle East and Africa Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous syste...
Latin America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Asia-Pacific Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, a...
Europe Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-ca...
North America Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, ...
Generic Drugs Market by type (Biosimilars, simple generic and super generic) by therapeutic drugs (Cardiovascular products, anti-infective products, anti-arthritis drugs, central nervous system drugs, anti-cancer dr...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.